# SUMATRIPTAN AND NAPROXEN SODIUM
> **ANDA202803** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2018-07-20
## Drug
- **FDA Application Number:** ANDA202803
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN AND NAPROXEN SODIUM
- **Generic name:** SUMATRIPTAN AND NAPROXEN SODIUM
- **Active ingredients:** NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARM
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2018-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202803)
---
*AI Analytics · CC0 1.0*